EUSA Pharma Handed Untitled Letter for Exclusion of Warning

Washington Drug Letter
A A
The FDA has handed an untitled letter to EUSA Pharma for promotional material that omitted contraindications and warnings about its prostate cancer diagnostic imaging agent.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00